Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

Tabelecleucel shows promising efficacy in treating EBV-positive PTLD, offering hope for patients resistant to previous ...

Last fall, the 29-year-old came to the Hospital of the University of Pennsylvania from his home in Switzerland for a rare ...

Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...

Omega-3 fatty acids by way of fish oil supplements didn't help to stave off renal decline in kidney transplant recipients, a ...

The alleged shooter, who was also wounded, wasn’t a longtime criminal who’d spent years skulking the streets. Instead, it was ...

Data presented at EHA 2025 demonstrated that the Epkinly / R-ICE combination produced an 87% ORR in transplant-eligible r/r ...

Martín Ojeda scored a goal and Pedro Gallese had his eighth shutout of the season to help Orlando City beat the Rapids 1-0 on ...

SELLAS Life Sciences' value hinges on the pivotal REGAL phase 3 trial in AML, with interim results showing promise. Click ...

Rates of grade III/IV acute GVHD at 3 months were 3% with cyclophosphamide-cyclosporin prophylaxis and 10% with standard ...

The BM12 CAST trial, a major clinical trial led by the Australasian Leukaemia & Lymphoma Group (ALLG) across New Zealand and Australian hospitals, will transform global blood stem cell transplant ...

Think about your best friend. What lengths would you go through to help there. Probably, although it's cliche, to the ends of ...